46 /100
MEDIUM RISK
Score updated Apr 13, 2026

JSPR

Jasper Therapeutics, Inc. — Stock Dilution Tracker

Track JSPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track JSPR — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
24%
🔄 Reverse Split 40%
• 50-day avg $1.21 approaching $1 threshold
• 7 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (7mo)
🔔 Track JSPR — Get forecast alerts →
💹 Market Data
Market Cap$22.46M
Shares Outstanding28.00M
Float21.88M
Cash$28.69M
Debt$1.24M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 0.4% shares (2025Q4 vs prior)
58 institutional holders · 20.25M shares
#1 Velan Capital Investment Management LP 2.67M shares
#2 MORGAN STANLEY 1.97M shares
#3 ACORN CAPITAL ADVISORS, LLC 1.79M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.02M
Days to Cover8.4
% of Float13.8%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
Track JSPR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking JSPR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required